Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02238327 · ClinicalTrials.gov registry record
Longitudinal Evaluation of HIV-associated Lung Disease Phenotypes
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 232
- Enrollment target
NCT02238327 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 232 participants.
The verdict
NCT02238327 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 232 participants
- Enrollment target
Study Summary
The overall hypotheses of this proposal are that discrete phenotypes of HIV Chronic Obstructive Pulmonary disease (COPD) differ in their trajectories, biomarkers, and risk factors and that persistent viral infection including residual HIV is linked to HIV COPD.
Interventions
- PROCEDURE blood draw
- RADIATION Quantitative CT scans
- PROCEDURE questionnaires
- PROCEDURE Lung function testing
- PROCEDURE Six-Minute walk test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 232 participants |
| Start Date | 2014-09 |
| Est. Completion | 2020-03-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02238327
The ClinicalTrials.gov registry entry for NCT02238327 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 232 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which blood draw is the first listed.
NCT02238327 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02238327 about?
NCT02238327 is a clinical study titled "Longitudinal Evaluation of HIV-associated Lung Disease Phenotypes". The overall hypotheses of this proposal are that discrete phenotypes of HIV Chronic Obstructive Pulmonary disease (COPD) differ in their trajectories, biomarkers, and risk factors and that persistent viral infection including residual HIV is linked to HIV COPD.
What is the current status of trial NCT02238327?
This trial is currently completed. The enrollment target is 232 participants. The study started on 2014-09. Estimated completion is 2020-03-02.
What interventions are being tested in trial NCT02238327?
The interventions under investigation include: blood draw (PROCEDURE), Quantitative CT scans (RADIATION), questionnaires (PROCEDURE), Lung function testing (PROCEDURE), Six-Minute walk test (PROCEDURE).
Who is sponsoring clinical trial NCT02238327?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.